Dr. Marvin E. Morris, an Instructor within the Division of Vascular Surgery and Endovascular Therapeutics, has received intramural funding from the UofL School of Medicine Basic Grant Program to further utilize the novel approach of invitro blood vessel mimics (BVM) to elucidate and inhibit neointimal hyperplasia. Neointimal hyperplasia is a dynamic and challenging clinical problem with no clear therapeutic intervention. The ultimate goal of Dr. Morris and his research team at the Cardiovascular Innovations Institute (CII) is to identify a locally delivered, clinically useful therapeutic entity to inhibit this process.